
By the age of four months, the retinas of mice carrying a mutation in the gene encoding PDE6? (left) are thin and lack rod photoreceptors (red). But mice who have had this mutation corrected through the PESpRY system (right) have much thicker retinas containing numerous rod cells.
CREDIT: Qin et al. Originally published in Journal of Experimental Medicine. https://doi.org/10.1084/jem.20220776
Researchers in China have successfully restored the vision of mice with retinitis pigmentosa, one of the major causes of blindness in humans. The study, to be published March 17 in the Journal of Experimental Medicine, uses a new, highly versatile form of CRISPR-based genome editing with the potential to correct a wide variety of disease-causing genetic mutations.
Researchers have previously used genome editing to restore the vision of mice with genetic diseases, such as Leber congenital amaurosis, that affect the retinal pigment epithelium, a layer of non-neuronal cells in the eye that supports the light-sensing rod and cone photoreceptor cells. However, most inherited forms of blindness, including retinitis pigmentosa, are caused by genetic defects in the neural photoreceptors themselves.
“The ability to edit the genome of neural retinal cells, particularly unhealthy or dying photoreceptors, would provide much more convincing evidence for the potential applications of these genome-editing tools in treating diseases such as retinitis pigmentosa,” says Kai Yao, a professor at the Wuhan University of Science and Technology.
Retinitis pigmentosa can be caused by mutations in over 100 different genes and is estimated to impair the vision of 1 in 4,000 people. It begins with the dysfunction and death of dim light-sensing rod cells, before spreading to the cone cells required for color vision, eventually leading to severe, irreversible vision loss.
Yao and colleagues attempted to rescue the vision of mice with retinitis pigmentosa caused by a mutation in the gene encoding a critical enzyme called PDE6?. To do this, Yao’s team developed a new, more versatile CRISPR system called PESpRY, which can be programmed to correct many different types of genetic mutation, regardless of where they occur within the genome.
When programmed to target the mutant PDE6? gene, the PESpRY system was able to efficiently correct the mutation and restore the enzyme’s activity in the retinas of mice. This prevented the death of rod and cone photoreceptors and restored their normal electrical responses to light.
Yao and colleagues performed a variety of behavioral tests to confirm that the gene-edited mice retained their vision even into old age. For example, the animals were able to find their way out of a visually guided water maze almost as well as normal, healthy mice and showed typical head movements in response to visual stimuli.
Yao cautions that much work still needs to be done to establish both the safety and efficacy of the PESpRY system in humans. “However, our study provides substantial evidence for the in vivo applicability of this new genome-editing strategy and its potential in diverse research and therapeutic contexts, in particular for inherited retinal diseases such as retinitis pigmentosa,” Yao says.
Original Article: New gene-editing technique reverses vision loss in mice
More from: Wuhan University of Science and Technology
The Latest Updates from Bing News
Go deeper with Bing News on:
Retinitis pigmentosa
- Emmerdale couple share son’s rare health diagnosis: What is Usher Syndrome?
The actors were speaking on Loose Women about their children's diagnosis and why they hope to raise awareness of the rare genetic condition.
- Retinitis Pigmentosa News, Research and Latest Updates
Keep abreast with the latest news related to Retinitis Pigmentosa there are 13 news items on Retinitis Pigmentosa that covers updates, breakthroughs and in-depth reports. We provide you with a ...
- Retinitis Pigmentosa: Genetics and Gene-Based Approaches to Therapy
Significant advances have been made in the understanding of the genetics of retinitis pigmentosa (RP), a clinically and genetically heterogeneous group of disorders; and over 50 genes underlying ...
- 2023 to 2030 Retinitis Pigmentosa Treatment Market Regional Outlook
Mar 24, 2023 (The Expresswire) -- “Retinitis Pigmentosa Treatment Market” Are a Collection of Information and Analysis Obtained From Diverse Sources to Aid Businesses in Comprehending the ...
- Blindness From Retinitis Pigmentosa Reversed With MD Stem Cells Treatment- Benefit May Last Years
John's vision had deteriorated to 20/200 in both eyes because of an inherited, genetic condition called retinitis pigmentosa or RP. He's remembers having difficulty seeing as early as 3 years old.
Go deeper with Bing News on:
Nano factory
- TMC’s decision to support GST Bill was a mistake: Mamata
Accusing the Centre of depriving West Bengal of its share of the Goods and Service Tax collected from the state, Chief Minister Mamata Banerjee on Tuesday said that the decision to support the passage ...
- Brewery battle: Cast your vote in the semifinals for RI's favorite beer maker
What makes a great brewery experience? Is it the beer? The atmosphere of the taproom? Seriously we are asking you.
- Micro nano Biosensor Market Prospects [2023-2030] | Global Industry Thriving | Latest Report with Top Countries Data
Global Micro nano Biosensor Market [2023-2030] research report gives most upcoming industry information on the ...
- Nvidia unveils Isaac Sim on Omniverse Cloud for better robot design
Nvidia has unveiled its Isaac Sim platform for its Omniverse Cloud, enabling engineers to work together remotely to simulate robots ...
- ROHM Establishes Ultra-High-Speed Control IC Technology that Maximizes the Performance of GaN ...
ROHM Semiconductor today introduced ultra-high-speed control IC technology that maximizes the performance of GaN and other high-speed switching ...